Wong S C, Macrae V E, McGrogan P, Ahmed S F
Bone and Endocrine Research Group, Royal Hospital for Sick Children, Glasgow, UK.
J Pediatr Gastroenterol Nutr. 2006 Aug;43(2):144-55. doi: 10.1097/01.mpg.0000226374.18494.14.
Childhood inflammatory bowel disease (IBD) especially those with Crohn disease is commonly complicated by faltering growth and pubertal delay. Pro-inflammatory cytokines are often elevated in IBD and may affect linear growth and puberty either systemically or at the level of the growth plate. Further study of the underlying mechanisms of the deleterious effects of cytokines on the growth plate may improve management of faltering growth in childhood IBD. Well-controlled clinical studies of the respective effect of nutritional support, immunomodulatory therapy, biological agents and growth and puberty promoting agents on managing faltering growth also require further attention.
儿童炎症性肠病(IBD),尤其是克罗恩病,常伴有生长发育迟缓及青春期延迟。IBD患者体内促炎细胞因子通常升高,可能会在全身或生长板水平影响线性生长和青春期发育。进一步研究细胞因子对生长板产生有害影响的潜在机制,可能会改善儿童IBD生长发育迟缓的管理。营养支持、免疫调节治疗、生物制剂以及促进生长和青春期发育药物对生长发育迟缓管理的各自效果的严格对照临床研究也需要进一步关注。